Searched for
GSK
Bharat Biotech slashes price of malaria vaccine MOSQIVAC by 40%Bharat Biotech has announced a significant price reduction of nearly 40 percent for its malaria vaccine MOSQIVAC. The reduction aims to pro...- US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatmentHibsago, GSK's new hepatitis B treatment, recently secured approval from the US FDA, allowing patients to better manage their condition aft...
- What is shingles? Viola Davis, Oscar-winning actress, opens up about her ‘terrified’ experience dealing with the infectionViola Davis candidly opens up about her battle with shingles, emphasizing the often-ignored pain linked to this condition. She points out i...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets ended lower on Wednesday as the Sensex fell 429 points and Nifty dropped over 173 points, snapping a two-session rally. Inve...
- Neuberg Diagnostics consolidates its Maharashtra operations with NM MedicalNeuberg Diagnostics has consolidated its operations with NM Medical in Maharashtra to enhance diagnostic and preventive healthcare. This pa...
- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities plunged on Monday as the Sensex fell 1,124 points and Nifty dropped over 360 points, wiping out nearly Rs 8 lakh crore in m...
- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...
- Novartis India MD Amitabh Dube appointed as OPPI presidentAmitabh Dube has been appointed as the new president of OPPI for a two-year term. Dube currently serves as the Country President and Managi...
- Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in USLannett Company, part of Aurobindo Pharma, has launched generic Advair Diskus in the US, making it the first complex inhalation product fro...
- Mahajan Imaging, Neuberg Diagnostics join hands to scale pathology, genomics in North IndiaMahajan Imaging and Neuberg Diagnostics have formed a strategic joint venture. This partnership aims to expand pathology and genomics servi...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Laurus Labs among 5 stocks hitting 52-week highs; surge up to 20% in a monthSix BSE 200 stocks hit fresh 52-week highs on Friday as the Sensex gained 331 points. Coforge, GSK Pharma, Glenmark Pharma, Laurus Labs, Or...
- Solar Industries among 5 stocks hitting 52-week highs; surge up to 22% in a monthFive BSE 200 stocks hit fresh 52-week highs on Thursday despite a weak market. Divi’s Laboratories led the pack with a 22% monthly gain.
- GSK India Q2 Results: Net profit grows 11% YoY to Rs 216 croreOur Q2 performance reflects an overall recovery with market share gains in several key promoted brands across all business units. We held l...
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...
- Pfizer to exit GSK's consumer health arm Haleon after spin-offBefore the spinoff, the holding company for the consumer health business will pay dividends to GSK and Pfizer. That will translate to GSK r...
- Teams to plan staff integration or separation in GSK-HUL dealGSK chief strategy officer said there is no clause in the deal that HUL has to retain all GSKCH employees.
- GSK Health names Navneet Saluja as India Sub-continent headSaluja's last assignment with GSK Consumer Healthcare was that of Area General Manager in the Middle East and Africa.
Load More
